Table 3.
Delay in clinical decisions—delays from a device-detected event to a clinical decision.
| Device-detected event | # of actionable device-detected events followed by a clinical decision (# of patients) |
# of days from actionable device-detected event to clinical decision Median (25th-75th percentile) |
P value | ||
| Control group | Remote group | Control group | Remote group | ||
| Lead impedances out of range | 2 (2) | 0 (0) | 24 (13-35) | - | - |
| VF detection/therapy off | 0 (0) | 0 (0) | - | - | - |
| AT/AF burden: at least 6 hrs of AT/AF in a single day | 5 (5) | 14 (7) | 51 (0-59) | 2 (1-3) | .51 |
| Fast V rate during AT/AF: Mean V rate of at least 100 bpm a day with at least 6 hrs of AT/AF | 0 (0) | 2 (2) | - | 9 (1-17) | - |
| Number of shocks delivered in an episode (at least two) | 1 (1) | 2 (2) | 0 (0-0) | 0 (0-0) | .50 |
| OptiVol threshold crossing for lung fluid accumulation | 11 (9) | 19 (15) | 29 (9-31) | 3 (1-6) | .002 |
| Total | 19 (15) | 37 (23) | 29 (3-51) | 2 (1-4) | .004 |